An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
The purpose of this study is to explore long-term safety, tolerability and efficacy of GSK2402968 in DMD subjects who previously participated in either DMD114117 or DMD114044.
Inclusion Criteria:
Exclusion Criteria:
Ciudad Autónoma de Buenos Aires, Buenos Aires C1125ABD, Argentina
Koebenhavn Oe, 2100, Denmark
Esplugues de Llobregat. Barcelona, 08950, Spain